Meaningful Patent Protection in Life Sciences

/in

Dr. Ute Kilger will be speaking on 21/11/2017 together with Dr. Klaus-Peter Döpfer (Director of Directorate 1412, Biotechnology, European Patent Office) as part of the SPARK Programme in Berlin on the extent of data required to ensure meaningful patent protection in life sciences. The need to validate inventions via data will be discussed in clear terms by means of case studies.

The SPARK programme, a worldwide network, was called into existence in 2006 by Stanford University (USA) and has been growing ever since. Its objective is to quickly establish new academic developments on the market. Further information